Metformin exacerbates diabetic amyotrophy via oxidative stress and gut microbiota alterations.

Illustration depicts a mechanistic pathway where metformin affects Desulfovibrio bacteria, leading to increased hydrogen sulfide production. This crosses the intestinal barrier, activates NOS1, induces 3-NT formation, and increases oxidative stress in the gastrocnemius muscle.